PMC:4636534 / 5155-5952 JSONTXT

{"project":"TEST0","denotations":[{"id":"26003789-157-163-67110","span":{"begin":462,"end":464},"obj":"[\"3185180\"]"}],"text":"When assessing the cost-effectiveness of DI, the initial question is whether adding an imaging test in a medical pathway does improve medical decision-making. Taking a hypothetical 100 % accuracy for a test would be used to assess changes in outcome by adding this particular test to the medical pathway. Only if the perfectly accurate test provides added value, it is reasonable to continue the analysis with the actual sensitivity and specificity of the test [20]. However, in many clinical situations imaging is already an existing standard part of the particular disease management. CEA is, therefore, used to compare potential new imaging technologies or imaging strategies to each other as well as to the current reference standard. We will focus on this second model throughout the article."}

{"project":"0_colil","denotations":[{"id":"26003789-3185180-67110","span":{"begin":462,"end":464},"obj":"3185180"}],"text":"When assessing the cost-effectiveness of DI, the initial question is whether adding an imaging test in a medical pathway does improve medical decision-making. Taking a hypothetical 100 % accuracy for a test would be used to assess changes in outcome by adding this particular test to the medical pathway. Only if the perfectly accurate test provides added value, it is reasonable to continue the analysis with the actual sensitivity and specificity of the test [20]. However, in many clinical situations imaging is already an existing standard part of the particular disease management. CEA is, therefore, used to compare potential new imaging technologies or imaging strategies to each other as well as to the current reference standard. We will focus on this second model throughout the article."}

{"project":"MyTest","denotations":[{"id":"26003789-3185180-29373353","span":{"begin":462,"end":464},"obj":"3185180"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"When assessing the cost-effectiveness of DI, the initial question is whether adding an imaging test in a medical pathway does improve medical decision-making. Taking a hypothetical 100 % accuracy for a test would be used to assess changes in outcome by adding this particular test to the medical pathway. Only if the perfectly accurate test provides added value, it is reasonable to continue the analysis with the actual sensitivity and specificity of the test [20]. However, in many clinical situations imaging is already an existing standard part of the particular disease management. CEA is, therefore, used to compare potential new imaging technologies or imaging strategies to each other as well as to the current reference standard. We will focus on this second model throughout the article."}

{"project":"2_test","denotations":[{"id":"26003789-3185180-29373353","span":{"begin":462,"end":464},"obj":"3185180"}],"text":"When assessing the cost-effectiveness of DI, the initial question is whether adding an imaging test in a medical pathway does improve medical decision-making. Taking a hypothetical 100 % accuracy for a test would be used to assess changes in outcome by adding this particular test to the medical pathway. Only if the perfectly accurate test provides added value, it is reasonable to continue the analysis with the actual sensitivity and specificity of the test [20]. However, in many clinical situations imaging is already an existing standard part of the particular disease management. CEA is, therefore, used to compare potential new imaging technologies or imaging strategies to each other as well as to the current reference standard. We will focus on this second model throughout the article."}